Nephros Inc
$ 3.34
0.30%
12 Jun - close price
- Market Cap 36,260,900 USD
- Current Price $ 3.34
- High / Low $ 3.35 / 3.21
- Stock P/E 47.71
- Book Value 0.99
- EPS 0.07
- Next Earning Report 2026-08-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.08 %
- 52 Week High 6.42
- 52 Week Low 2.66
About
Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.
Analyst Target Price
$7.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-03-12 | 2025-11-06 | 2025-08-07 | 2025-05-15 | 2025-03-24 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-07 | 2023-11-08 | 2023-08-09 |
| Reported EPS | 0.01 | 0.01 | 0.03 | 0.02 | 0.05 | 0.03 | 0.02 | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 |
| Estimated EPS | 0.01 | -0.01 | -0.02 | -0.02 | -0.005 | -0.015 | -0.02 | -0.01 | -0.04 | -0.02 | -0.05 | -0.05 |
| Surprise | 0 | 0.02 | 0.05 | 0.04 | 0.055 | 0.045 | 0.04 | -0.02 | 0.02 | -0.04 | 0.03 | 0.01 |
| Surprise Percentage | 0% | 200% | 250% | 200% | 1100% | 300% | 200% | -200% | 50% | -200% | 60% | 20% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-06 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NEPH
2026-06-12 21:39:25
Nephros Inc. director Arthur H. Amron received an equity grant of 3,574 shares of Common Stock as compensation for board service, increasing his direct holdings to 138,456 shares. He also holds outstanding stock options for 7,050 shares exercisable at $1.47 expiring in 2035 and 7,323 shares exercisable at $2.14 expiring in 2034, which vest in annual installments. This transaction was a grant, not a market purchase or sale.
2026-05-11 18:39:01
Nephros, Inc. (NASDAQ:NEPH) shareholders experienced a 15% surge in shares after the company released its latest quarterly results. The company slightly exceeded revenue expectations at US$5.2m, and its statutory EPS aligned with analyst appraisals at US$0.01. Following these results, analysts increased their price target to US$7.00, despite a projected decrease in EPS for 2026, indicating that anticipated revenue growth is expected to offset the impact of lower earnings.
2026-05-11 11:39:16
Nephros, Inc. recently reported its first-quarter results, showing a 15% share surge despite mixed analyst reactions. While the company's Q1 revenues beat expectations, analysts lowered their EPS forecasts for 2026 but increased revenue predictions and raised the price target to US$7.00. Nephros is expected to grow faster than the industry, although a warning sign has been identified, suggesting caution for investors.
2026-05-10 05:10:33
Nephros, Inc. (NEPH) reported record Q1 2026 revenue of $5.2 million, a 7% increase year-over-year, driven by strong programmatic growth and an expanding customer base. However, the company experienced significant margin compression and a 75% drop in net income due to tariffs, currency effects, and a strategic shift to lower-margin markets. Management expects margins to improve later in the year as tariff headwinds ease and new strategies take effect.
2026-05-09 12:40:05
Nephros, Inc. reported a record Q1 2026 revenue of $5.2 million, a 7% increase from the prior year, primarily driven by strong programmatic business growth. Despite the revenue increase, gross margin declined to 57% due to tariffs, currency pressures, and a strategic shift towards lower-margin commercial applications. The company remains optimistic about its long-term growth trajectory, focusing on market expansion, recurring revenue models, and educational initiatives, while actively seeking to mitigate external cost pressures.
2026-05-09 01:39:03
Nephros, Inc. reported record Q1 2026 revenue of $5.2 million, driven by strong programmatic growth and an expanding customer base, but faced significant margin pressure. Gross margin dropped to 57% from 65% due to tariffs, currency effects, and a shift to lower-margin commercial markets, leading to a substantial decline in net income and adjusted EBITDA. The company is implementing mitigation strategies and expects margin improvement later in the year as tariff impacts subside and service offerings increase.
